Showing results (1521-1530 of 1,560) with videos related to
Sort By:
Pageof 156
Climacteric : the Journal of the International Menopause Society|June 23, 2025
Practices and challenges in the management of the menopause in the Asia-Pacific Menopause FederationSeng Bin Ang, Felicia Clara Jun Hui Tan, Stella Rizalina Sasha Sugianto, et al.Journal of Menopausal Medicine|May 10, 2025
Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024Seng Bin Ang, Stella Rizalina Sasha Sugianto, Felicia Clara Jun Hui Tan, et al.Nature Medicine|August 2, 2001
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityT Yamauchi, J Kamon, H Waki, et al.Nature|June 13, 2003
Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsToshimasa Yamauchi, Junji Kamon, Yusuke Ito, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2023
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney diseaseShunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, et al.Nature Communications|May 30, 2024
An NLR paralog Pit2 generated from tandem duplication of Pit1 fine-tunes Pit1 localization and functionYuying Li, Qiong Wang, Huimin Jia, et al.Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 14, 2025
Office and home blood pressure and their difference according to frailty status among community-dwelling older adults: the NOSE studyYuka Ohata, Mai Kabayama, Kayo Godai, et al.Cell Metabolism|July 10, 2007
Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intakeNaoto Kubota, Wataru Yano, Tetsuya Kubota, et al.Diabetes Research and Clinical Practice|February 8, 2022
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonistsKazuo Kobayashi, Masao Toyoda, Nobuo Hatori, et al.Human Molecular Genetics|April 23, 2004
A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models generated by a large-scale ENU mutagenesis programMaki Inoue, Yoshiyuki Sakuraba, Hiromi Motegi, et al.Pageof 156